Joseph Bayne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joseph Bayne has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alexander N. Katchman
Division of Cardiology, Department of Medicine, and
1 shared publication - Andrew R. Marks
Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
1 shared publication - Anirudh Gorti
Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA
1 shared publication - Daniel Roybal
Department of Pharmacology, and
1 shared publication - Deepak Saluja
Division of Cardiology, Columbia University Irving Medical Center, New York, NY 10032, USA
1 shared publication - Edward J. Ciaccio
Division of Cardiology, Columbia University Irving Medical Center, New York, NY 10032, USA
1 shared publication
Latest Publications
- 6 June 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (11)
Heterogeneity of the action potential duration is required for sustained atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia and accounts for substantial morbidity and mortality. Recently, we created a mouse model with spontaneous and sustained AF caused by a mutation in the Na V 1.5 channel (F1759A) that enhances persistent Na + current, thereby enabling the investigation of molecular mechanisms that cause AF and the identification of potentially novel treatment strategies. The mice have regional heterogeneity of action potential duration of the atria similar to observations in patients with AF. In these mice, we found that the initiation and persistence of the rotational reentrant AF arrhythmias, known as spiral waves or rotors, were dependent upon action potential duration heterogeneity. The centers of the rotors were localized to regions of greatest heterogeneity of the action potential duration. Pharmacologically attenuating the action potential duration heterogeneity reduced both spontaneous and pacing-induced AF. Computer-based simulations also demonstrated that the action potential duration heterogeneity is required to generate rotors that manifest as AF. Taken together, these findings suggest that action potential duration heterogeneity in mice and humans is one mechanism by which AF is initiated and that reducing action potential duration heterogeneity can lessen the burden of AF.
- 6 June 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (11)
Heterogeneity of the action potential duration is required for sustained atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia and accounts for substantial morbidity and mortality. Recently, we created a mouse model with spontaneous and sustained AF caused by a mutation in the Na V 1.5 channel (F1759A) that enhances persistent Na + current, thereby enabling the investigation of molecular mechanisms that cause AF and the identification of potentially novel treatment strategies. The mice have regional heterogeneity of action potential duration of the atria similar to observations in patients with AF. In these mice, we found that the initiation and persistence of the rotational reentrant AF arrhythmias, known as spiral waves or rotors, were dependent upon action potential duration heterogeneity. The centers of the rotors were localized to regions of greatest heterogeneity of the action potential duration. Pharmacologically attenuating the action potential duration heterogeneity reduced both spontaneous and pacing-induced AF. Computer-based simulations also demonstrated that the action potential duration heterogeneity is required to generate rotors that manifest as AF. Taken together, these findings suggest that action potential duration heterogeneity in mice and humans is one mechanism by which AF is initiated and that reducing action potential duration heterogeneity can lessen the burden of AF.